Email updates

Keep up to date with the latest news and content from Diagnostic Pathology and BioMed Central.

Open Access Highly Accessed Research

High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma

Björn Nodin, Marie Fridberg, Liv Jonsson, Julia Bergman, Mathias Uhlén and Karin Jirström*

Diagnostic Pathology 2012, 7:82  doi:10.1186/1746-1596-7-82

Article Metrics

2569
Total accesses


3
BioMed Central citations

Article metric FAQ

Accesses  

  • Last 30 days: 65 accesses
  • Last 365 days: 782 accesses
  • All time: 2569 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information

Cited by